← Leaderboards
Zenaide Maria Quezado
Reveragen Biopharma, Inc.
$112,500
Attributed
$225,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$225,000 · 1
By mechanism
R41$225,000 · 1
Top collaborators
- Jesse Damsker1 shared
Most similar at Reveragen Biopharma, Inc.
Same institution · by research overlap
- Eric P Hoffman$47,884,792
- Paula R Clemens$13,640,837
- Jesse Damsker$1,130,321
Others in their field
Top investigators on “Acute Pain”
- Russell E Ware · Duke University$24,864,158
- Jon David Levine · University Of California, San Francisco$23,267,326
- David J Julius · University Of California, San Francisco$23,044,206
- Maurizio Fava · Massachusetts General Hospital$22,056,589
- Michael Rutledge Debaun · Vanderbilt University Medical Center$19,953,528
- Abraham Aizer Brody · New York University School Of Medicine$18,899,006
Research focus
Acute PainAdherence (Attribute)Adrenal Cortex HormonesAdverse EffectsAffectAfferent NerveAnalgesicsAnalogAnti-InflammatoryAnti-Inflammatory AgentsAsthmaBiochemicalBlindedBlood VesselsBrainCare DeliveryCell Adhesion MoleculesChildClinical TrialsCollaborationsCytokineDexamethasoneEmergency SituationAcute Chest Syndrome